
Sign up to save your podcasts
Or


In today’s healthcare focused episode, Motley Fool analysts Maria Gallagher and Emily Flippen discuss the prospects for 10x Genomics, a healthcare tech company looking to reform the way researchers discover single cell gene expression.
Stocks: 10x Genomics (NASDAQ: TXG)
Check out more of our content here:
Podcasts
Youtube
Reach us by Email @ [email protected]
By The Motley Fool4.5
825825 ratings
In today’s healthcare focused episode, Motley Fool analysts Maria Gallagher and Emily Flippen discuss the prospects for 10x Genomics, a healthcare tech company looking to reform the way researchers discover single cell gene expression.
Stocks: 10x Genomics (NASDAQ: TXG)
Check out more of our content here:
Podcasts
Youtube
Reach us by Email @ [email protected]

3,223 Listeners

806 Listeners

943 Listeners

1,604 Listeners